Full-Time

Manager – Sales Operations

Confirmed live in the last 24 hours

Atropos Health

Atropos Health

51-200 employees

Provides personalized real world evidence for physicians

Compensation Overview

$150k - $170k/yr

Mid, Senior

No H1B Sponsorship

Remote in USA

Candidates must be currently authorized to work in the United States on a full-time basis. No visa sponsorship is available.

Category
Sales Development Representative
Sales & Account Management
Required Skills
Lead Generation
Hubspot
Data Analysis
PowerPoint/Keynote/Slides
Requirements
  • 3+ years of experience in sales or revenue operations in the pharmaceutical, biotechnology or medical device industries.
  • Proven track record of working with Sales & Marketing teams.
  • Exceptional powerpoint skills
  • Strong understanding of the health tech ecosystem.
  • Knowledge of healthcare regulations impacting sales strategies.
  • Proficiency in CRM systems (HubSpot) and other sales effectiveness & analytical tools and software.
  • Prior experience building/leading/managing a Lead Generation team.
  • Exceptional written and oral communication skills.
  • Ability to analyze data and derive actionable insights.
  • Experience with sales analytics tools.
  • Strong strategic thinking and execution capabilities.
  • Ability to clearly and concisely distill complex ideas and projects to non-technical stakeholders.
  • Attention to detail, adherence to process and organization.
  • Must have the ability to travel.
Responsibilities
  • Enable channel partner operations and programs (GCP, AWS, etc)
  • Lead Sales Development Representative (SDR) Program.
  • Serve as CRM-Hubspot expert for Commercial Org.
  • Create pipeline and forecasting reports for internal meetings.
  • Work collaboratively with Sales & Marketing to implement marketing campaigns.
  • Recommend data-driven approaches for tracking sales performance.
  • Develop and implement sales strategies aligned with company goals.
  • Establish key performance indicators (KPIs) for measuring success.
  • Drive process improvements to enhance operational efficiency.
  • Foster cross-functional collaboration to support revenue growth.
  • Support Sales/Corp Dev with channel partner operations and programs.
  • Enforce use of brand standards on customer & prospect facing materials.

Atropos Health provides personalized real-world evidence to help physicians make informed clinical decisions. Their main product is a digital consultation service that allows doctors to quickly access and analyze patient data to answer complex medical questions within 24 hours. This service addresses the 'Evidence Gap' in clinical research, which occurs when traditional studies exclude important patient groups. Atropos Health differentiates itself from competitors by utilizing observational research and technology developed at Stanford University, ensuring that their evidence is relevant and applicable to diverse patient populations. The company's goal is to enhance clinical decision-making by providing timely and accurate information to healthcare providers, hospitals, and research institutions through a subscription-based model.

Company Size

51-200

Company Stage

Series B

Total Funding

$47M

Headquarters

Palo Alto, California

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • Atropos Health's federated data network includes over 300 million patient records.
  • Collaboration with Merck accelerates real-world evidence generation for life-saving treatments.
  • AI model training on their network supports innovation across healthcare stakeholders.

What critics are saying

  • Emerging competition from AI-driven platforms like Arcadia's precision medicine solution.
  • Tech giants like Amazon entering healthcare could divert potential clients.
  • Need for continuous innovation to maintain competitive edge in rapidly advancing AI healthcare.

What makes Atropos Health unique

  • Atropos Health offers rapid, personalized real-world evidence for clinical decisions within 24 hours.
  • Their GENEVA OS platform enables secure, real-time queries without data transfers.
  • Partnerships with institutions like Emory Healthcare enhance Atropos' evidence generation capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Retirement Plan

Parental Leave

Flexible Work Hours

Remote Work Options

Home Office Stipend

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

3%
Hit Consultant
Mar 19th, 2025
Atropos Unveils Largest De-Identified Patient Data Source, New Tech For Data Security & Linkage

Atropos Unveils Largest De-Identified Patient Data Source, New Tech for Data Security Linkage. by Syed Hamza Sohail 03/19/2025 Leave a Comment. What You Should Know:–  Atropos Health, a leader in automating high-quality real-world evidence (RWE), has launched Nodal Patient Deidentification and Query Time Interval Encoding (Nodal Deid) within the GENEVA OS platform for Atropos Evidence Network members.–  This advancement allows members to securely enhance patient longitudinal records with deidentified data mapped to the HIPAA safe harbor standard while retaining full control over their data. Linkage occurs only at query time, eliminating the need for data transfers and ensuring source data remains protected.Atropos Health Enhances Real-World Data Utilization with Nodal Deid and GENEVA OS™Atropos Health, developer of GENEVA OS™, is advancing real-world data (RWD) analysis to close evidence gaps in healthcare. By eliminating traditional data duplication and transfer, Nodal Deid enables secure, real-time queries across the Atropos Evidence Network via ChatRWD®, delivering publication-grade insights in minutes. Mortality data from Veritas Data Research is automatically integrated, with quality assessed through Real World Fitness Score® (RWFS).Health systems can bridge data gaps while maintaining full control and generating passive revenue

Hit Consultant
Feb 25th, 2025
Emory Healthcare Taps Atropos Health As Real-World-Evidence Partner

What You Should Know:– Atropos Health, a pioneer in in translating clinical data into personalized real-world evidence (RWE) and insights, announced its selection by Emory Healthcare, an academic health system in Georgia, to generate evidence from real-world data (RWD) through a new decision-making tool for clinicians.– The tool aims to improve patient outcomes and lower costs through medication solutions.Transforming Healthcare with Real-World Evidence: Atropos Health and Emory CollaborationAtropos Health, the developer of GENEVA OS, is revolutionizing healthcare by delivering rapid, data-driven evidence through a robust network of real-world data. By partnering with healthcare and life sciences organizations, Atropos Health aims to close evidence gaps from bench to bedside, enhance patient outcomes with data-driven care, and expedite groundbreaking research in medicine.Advancing Patient Care Through Data-Driven InsightsRapid Evidence Generation: Atropos Health enables real-time clinical decision-making through advanced analytics and observational studies.Atropos Health enables real-time clinical decision-making through advanced analytics and observational studies. Emory Pilot Program: Emory is leveraging Atropos Health’s platform to access vast, previously untapped clinical data, enhancing medication formulary design and care protocols.Emory is leveraging Atropos Health’s platform to access vast, previously untapped clinical data, enhancing medication formulary design and care protocols. Real-World Impact: The collaboration aims to directly improve patient care by informing evidence-based treatment strategies.The Atropos Evidence™ Network & Green Button™Unparalleled Data Access: The Atropos Evidence™ Network includes over 300 million patient records, supporting research on both large national datasets and localized Emory data.The Atropos Evidence™ Network includes over 300 million patient records, supporting research on both large national datasets and localized Emory data. Seamless Clinician Support: Emory clinicians can utilize the Green Button™ for immediate access to real-world evidence, using supervised evidence development or the AI-powered ChatRWD® for generating observational study results within minutes.Industry Leadership & InnovationAchieving the Quadruple Aim: “Closing the evidence gap is key to achieving the quadruple aim in healthcare,” said Dr. Brigham Hyde, CEO and co-founder of Atropos Health

Hit Consultant
Jan 14th, 2025
Arcadia Launches Ai-Powered Precision Medicine Solution

What You Should Know:– Arcadia, a healthcare data platform, announced a new AI-driven precision medicine solution designed to identify patients with undiagnosed or misdiagnosed conditions who are at risk of poor health outcomes.– The new AI-enabled solution empowers healthcare providers to connect these patients with appropriate treatments, ultimately improving their health and reducing the total cost of care.AI-Driven Insights for Precision MedicineArcadia launched its precision medicine offering with an initial model developed by Atropos Health, with plans to add more models throughout 2025. This collaboration builds on an existing partnership between the two companies, further integrating Atropos Health’s real-world evidence-generation capabilities into Arcadia’s data platform.Built on Arcadia’s Foundry development platform, the solution allows healthcare providers to:Identify at-risk patients: Leverage AI models to identify patients based on risk factors, demographics, and clinical data.Leverage AI models to identify patients based on risk factors, demographics, and clinical data. Notify care teams: Alert primary care physicians, specialists, and care managers about patients requiring intervention.Alert primary care physicians, specialists, and care managers about patients requiring intervention. Deliver actionable analytics: Integrate insights into existing workflows, such as EHR systems, through SMART-on-FHIR applications.Integrate insights into existing workflows, such as EHR systems, through SMART-on-FHIR applications. Track program effectiveness: Gain insights into the number of patients identified and outcomes achieved through subsequent testing and diagnosis.Strengthened LeadershipArcadia has also bolstered its board of directors with the addition of two experienced healthcare executives:Dr. Scott Ransom: A physician executive with over 30 years of experience in healthcare transformation.A physician executive with over 30 years of experience in healthcare transformation

Drug Discovery Trends
Jan 10th, 2025
Merck taps Atropos Health to accelerate real-world evidence generation

In May 2024, Atropos Health raised $33 million in funding, with participation from Cencora Ventures, McKesson Ventures, and Merck Global Health Innovation Fund.

Hit Consultant
Jan 10th, 2025
Atropos Health Collaborates With Merck To Accelerate Real-World Evidence Generation

What You Should Know:– Atropos Health, a pioneer in real-world evidence (RWE) generation, announced a collaboration with Merck to leverage its innovative platform for rapid insights and analytics from real-world data (RWD).– The strategic partnership will enable Merck’s data science and RWE teams to conduct advanced analyses and generate publication-grade studies in less than 48 hours.– The collaboration follows Atropos Health’s recent launch of ChatRWD™, a groundbreaking generative AI application for rapid RWE generation. In May 2024, the company also secured $33M in funding to advance its AI-driven approach to health data analysis.Accelerating RWE for Life Savings TreatmentsMerck will utilize a suite of Atropos Health’s services, including:GENEVA OS™: A generative evidence acceleration operating system that facilitates rapid cohort creation and advanced analytics.A generative evidence acceleration operating system that facilitates rapid cohort creation and advanced analytics. Green Button™: A tool that simplifies the process of asking clinical questions and generating RWE.A tool that simplifies the process of asking clinical questions and generating RWE. Atropos Evidence™ Network: Access to the industry’s largest federated healthcare data network, with over 300 million patient records.Access to the industry’s largest federated healthcare data network, with over 300 million patient records. Alexandria™: A repository of existing studies that can be rerun on local data to generate novel insights.A repository of existing studies that can be rerun on local data to generate novel insights. Forge™: A low-code research platform for rapid cohort creation and advanced patient studies.A low-code research platform for rapid cohort creation and advanced patient studies